starting in march 1982 , 42 consecutive patients with minimal or intermediate advanced disease ( lymph node metastases less than 10 cm , lung nodules less than 5 cm ) began a 0.2-mg/kg vinblastine pvb regimen , provided that serum alpha-fetoprotein ( afp ) levels were not greater than 1000 ng/ml and human chorionic gonadotropin ( hcg ) values were not greater than 50,000 miu/ml .
C0042670
vinblastine
C1882268
pvb